SUMMARY A simple method for quantifying visual field survival was devised to assess the progress of chronic simple glaucoma in 36 patients treated with timolol maleate over a 3-year period. Routine tonometric monitoring of the intraocular pressure (IOP) was carried out in conjunction with these Goldmann field studies. Statistical analysis revealed that field survival measurement provided a more consistent clinical guide to the progress of glaucoma under treatment than did IOP (p << 0-001). Timolol therapy was associated with sustained IOP reductions of 24 3-34 5%, and 63% of those treated who were monitored for field survival showed no significant field loss. The observed relationships of IOP to field survival are discussed.
Traditionally the assessment of antiglaucoma therapeutic agents has relied heavily on measurements of intraocular pressure (IOP), even though the susceptibility of individuals to ocular hypertension is highly variable.' 2 Indeed IOP is subject to volatile fluctuation according to diurnal factors, stress, and the treatment-assessment interval.3-5 Noncompliance with treatment is a factor to be considered, and some patients resume their therapy a few days or even hours before a clinical assessment, thus giving a false sense of control. Since the aim of treatment is to prevent loss of visual field, any definitive assessment of therapeutic benefit should logically be based on field survival.
In the present study visual field survival has been quantified from Goldmann perimetry data. The effectiveness of timolol maleate in the treatment of open-angle glaucoma has been assessed both in terms of its hypotensive action and its influence on visual field survival.
Patients and methods
Thirty-six patients with open-angle glaucoma were studied. Twenty-three cases were newly diagnosed, and 13 were patients whose progress or compatibility with other drugs was unsatisfactory. Nineteen were males (mean age 67-6, SD 10-1 years) and 17 were females (mean age 71-9, SD 9-8 years). Three women were monocular, leaving a total of 69 eyes under study. Introduction to the trial was gradual, and there was no loss of patients among the study group, although 2 patients had unilateral trabeculectomies during the course of treatment.
A regimen of 0-25% gutt. timolol twice daily was prescribed to all patients, and periodic IOP measuremerts were made by applanation tonometry. Visual field assessment was carried out by routine Goldmann perimetry, with either the 14e or I14e isoptre being used consistently for each eye. Quantitative approximations of total field area were obtained from the Goldmann traces by simply compiling the sums of the lengths of effective visual area subtended by each of the 24 150 radii on the recording charts ( Figs. 1 and 2 ). Internal field defects were thus subtracted wherever they intersected each radius. Quantitative field data and tonometric IOP data were displayed graphically, and least-squares analysis was performed digitally with an Apple II computerised line-fitting programme.
Results
The hypotensive responses to timolol therapy in the total study group and the newly diagnosed subgroup are shown in Table 1 . There was no significant difference in IOP response in the 2 groups despite the inclusion of patients experiencing problems with previous forms of therapy in the total study group. The hypotensive effect associated with timolol therapy was sustained throughout the trial period. An evaluation of IOP and field survival trends in individual patients is shown in Table 2 . Comparative. measurements of field survival and IOP were carried out concurrently after the initial sharp hypotensive effect of timolol therapy had settled (i.e., in the 'poststabilisation period'). Statistically, the field data provided a substantially more consistent index of the progress of these treated patients than did IOP measurements. The mean 95% confidence range for field survival trends in individuals was one-third of that for IOP trends, and the scatter of confidence limits in the population was 3-fold lower using the field data. This ratio of least squares confidence limits is highly significant (p<<0-001).
In Table 3 these findings are correlated to show the relationship of field survival to IOP both in terms of post-stabilisation IOP trends and mean IOP control. Note that only one eye showed a significant IOP increase, and that this was associated with significant field loss. However, a large proportion of the eyes Fig. 7 shows the findings from a patient whose continued hypotensive response to abnormally low levels during timolol therapy was nevertheless associated with field stability in both eyes. 
Discussion
There is a natural tendency among clinicians when interpreting perimetry charts to lay special emphasis on the detailed configuration of internal field defects. In the present study we (Fig. 9) . It should be stressed that this microcomputer is independent of the perimetry apparatus and is capable of storing, analysing, and comparing field information from distant clinics and previous patient records. Thus there is no interference with the established clinical routine of the optometric department. Moreover, the mechanical simplicity and reliability of Goldmann perimetry is preserved, along with the important personal contribution of the professional optometrist. Any data relevant to an individual patient's case may be readily entered on to the microcomputer memory disc along with the perimetry recordings. Thus tabulations of IOP and field survival such as those shown in Figs. 3-8 could be printed out periodically as required. Information could be retrieved by reference to a variety of parameters (e.g., age, sex, admission date, drug regimen, initial field, or IOP values, etc.), thus greatly facilitating statistical analysis for research purposes. The flexibility of the Apple 1I computer system would allow for easy updating of patient information, thereby minimising the burden on administrative staff and consultants. Appointment letters could be automatically printed out and addressed according to the date and result of the previous assessment.
The potential of such a system for providing chronological progress reports at a glance has generated considerable interest, and further developments are under way, including a double-blind trial of the effects of timolol and pilocarpine. Ease of use of the system by personnel without computer expertise is a prime objective of this co-operative venture between ophthalmological and computer systems staff. 
